1-15 of 74
Encaleret in Autosomal Dominant Hypocalcemia Type 1: Clinical Implications From the Phase 3 CALIBRATE Trial
EndocrinologyEncaleret in Autosomal Dominant Hypocalcemia Type 1: Clinical Implications From the Phase 3 CALIBRATE Trial
Michael A. Levine, MD
Expert Answers to Your Pressing Questions on the CALIBRATE Trial in ADH1
EndocrinologyExpert Answers to Your Pressing Questions on the CALIBRATE Trial in ADH1
Michael A. Levine, MD
AACE Guidance in Action: When to Suspect and Treat Hypercortisolism in Adults with Diabetes
CME/CEAACE Guidance in Action: When to Suspect and Treat Hypercortisolism in Adults with Diabetes
Susan L Samson, MD, PhD, FRCPC, FACE
Lawrence Blonde, MD, FACP, FACE
A Q-Challenge™ Replay: Advancing Precision Diagnosis and Treatment Strategies in Acromegaly
CME/CE Broadcast ReplayA Q-Challenge™ Replay: Advancing Precision Diagnosis and Treatment Strategies in Acromegaly
Maria Fleseriu, MD, FACE
Shlomo Melmed, MBChB
Elise M. Brett, MD, FACE
Cushing's at the Core: Leading-Edge Strategies for Diagnosis and Medical Management of Cushing Syndrome
CME/CECushing's at the Core: Leading-Edge Strategies for Diagnosis and Medical Management of Cushing Syndrome
Honey East, MD
Amir H. Hamrahian, MD
Rosario Pivonello, MD, PhD
The Cortisol Clue: Diagnosing Hypercortisolism in People with Difficult-to-Control Cardiometabolic Conditions
CME/CEThe Cortisol Clue: Diagnosing Hypercortisolism in People with Difficult-to-Control Cardiometabolic Conditions
Hanford Yau, MD, CCD, FACP, FACE
Eden Miller, DO, D-ACD, D-ABOM
- advertisement
Jennifer Goldman, PharmD, CDCES, BC-ADM-FCCP
Francisco Javier Ampudia-Blasco, MD, PhD
Continuing the Search: New Data on Hypercortisolism Prevalence in Difficult-to-Control Metabolic Conditions
CME/CEContinuing the Search: New Data on Hypercortisolism Prevalence in Difficult-to-Control Metabolic Conditions
Christian Mende, MD, FACP, FACN, FASN, FASH, FAHA
Deepak Bhatt, MD, MPH, MBA, FACC, FAHA
DKA in the Real World: Evidence and Cases that Matter
CME/CEDKA in the Real World: Evidence and Cases that Matter
Carol Wysham, MD
Samuel Seidu, MD, FRCP(Edin), FRCGP
Grooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction
CME/CEGrooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert
Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC
Pam R. Taub, MD, FACC, FASPC
Leveraging CGM to Its Full Potential in People with T2D
CME/CELeveraging CGM to Its Full Potential in People with T2D
John E. Anderson, MD
Davida F. Kruger, CNP
DKA in Focus: What the New Consensus Means for Practice
CME/CEDKA in Focus: What the New Consensus Means for Practice
Ketan Dhatariya, MBBS, MSc, MD, MS, FRCP, PhD
Jennifer Sherr, MD, PhD
- advertisement
Applying Advances in Practice: Case-Based Look at Selecting Therapy for Cushing Syndrome
CME/CEApplying Advances in Practice: Case-Based Look at Selecting Therapy for Cushing Syndrome
Lewis S. Blevins, Jr, MD
James W. Suliburk, MD, FACS
Breaking Ground: 2025 Milestones in Cushing Syndrome and Looking Forward to 2026
CME/CEBreaking Ground: 2025 Milestones in Cushing Syndrome and Looking Forward to 2026
Deepak Bhatt, MD, MPH, MBA, FACC, FAHA
Amir H. Hamrahian, MD
No Patient with CKD Left Behind! Emerging CKD Therapies in T1D
CME/CENo Patient with CKD Left Behind! Emerging CKD Therapies in T1D
Richard E. Pratley, MD
David Cherney, MD, PhD
prof. Hiddo Heerspink
